Postkoitale Kontrazeption

Goeckenjan, Maren; Rabe, T.; Strowitzki, T.

doi:10.1007/s10304-011-0463-5

Cited by 1 publication

(1 citation statement)

References 25 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To prevent unwanted pregnancies, the World Health Organization (WHO) recommends the use of emergency contraception (EC). The WHO distinguishes between the copper intrauterine device (Cu IUD) for insertion into the cavum uteri, the oral EC with the active ingredients levonorgestrel (LNG) and ulipristal acetate (UPA) and the combined oral contraceptives (COCs, Yuzpe method) [1], which are not recommended in Germany, as fewer adverse effects and higher clinical efficacy were associated with LNG and UPA [2][3][4]. In Germany, the Cu IUD is a prescription-only medicine (POM), whereas the oral ECanalogous to many other countries worldwide [5]-has been available since March 2015 as an over-the-counter (OTC) medicine without prescription [6,7].…”

Section: Introductionmentioning

confidence: 99%

A Nationwide Mystery Caller Evaluation of Oral Emergency Contraception Practices from German Community Pharmacies: An Observational Study Protocol

et al. 2021

View full text Add to dashboard Cite

To prevent unwanted pregnancies, oral emergency contraception (EC) with the active ingredients levonorgestrel (LNG) and ulipristal acetate (UPA) is recommended by the guidelines of the German Federal Chamber of Pharmacists (BAK). In this respect, community pharmacies (CPs) in Germany have a major responsibility for information gathering, selecting the appropriate medicine, availability and pricing, among other things. Therefore, it would be appropriate to conduct a study with the aim of investigating information gathering, a possible recommendation as well as availability and pricing for oral EC in German CPs. A representative nationwide observational study based on the simulated patient methodology (SPM) in the form of covert mystery calls will be conducted in a random sample of German CPs stratified according to the 16 federal states. Each selected CP will be randomly called once successfully by one of six both female and male trained mystery callers (MCs). The MCs will simulate a product-based scenario using the request for oral EC. For quality assurance of the data collection, a second observer accompanying the MC is planned. After all mystery calls have been made, each CP will receive written, pharmacy-specific performance feedback. The only national SPM study on oral EC to date has identified deficits in the provision of self-medication consultations with the help of visits in the CPs studied. International studies suggest that UPA in particular is not always available. Significant price differences could be found analogous to another German study for a different indication.

show abstract

Section: Introductionmentioning

confidence: 99%